Evopoint Biosciences Adjusts IPO Allocation on Strong Online Demand

MT Newswires Live

昨天

Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.

The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.

The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2664385110"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664385110\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664385110?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-04 11:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664385110","market":"fut","top_or_hot":-1,"title":"Evopoint Biosciences Adjusts IPO Allocation on Strong Online Demand","media":"MT Newswires Live","content":"<html><body><p> Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.</p><p>The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.</p><p>The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. <a href=\"https://laohu8.com/S/601211\">Guotai Haitong Securities</a> serves as lead underwriter, with <a href=\"https://laohu8.com/S/CGXYF\">China Galaxy Securities</a> as joint lead underwriter.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Evopoint Biosciences Adjusts IPO Allocation on Strong Online Demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEvopoint Biosciences Adjusts IPO Allocation on Strong Online Demand\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-09-04 11:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.</p><p>The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.</p><p>The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. <a href=\"https://laohu8.com/S/601211\">Guotai Haitong Securities</a> serves as lead underwriter, with <a href=\"https://laohu8.com/S/CGXYF\">China Galaxy Securities</a> as joint lead underwriter.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4127","symbol_name":"投資銀行業與經紀業","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2664385110","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664385110","pubTimestamp":1788491484,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Evopoint Biosciences  moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688837":"信诺维-U","BK4127":"投资银行业与经纪业","FRHC":"Euronext CAC Health Care","REDS":"RPM Republican Senate ETF","KCE":"SPDR KBW Capital Markets ETF","IPOS":"Renaissance International IPO ETF"},"translate_title":"Evopoint Biosciences 因在线需求强劲而调整 IPO 分配","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688837":0.9,"FRHC":1.5,"KCE":1.5,"REDS":1.5,"IPOS":1.5},"content_text":"Evopoint Biosciences (SHA:688837) moved 10% of the post-strategic offering shares to online from offline following high demand during the online subscription of the initial public offering in Shanghai's STAR Market board.The final allocation now stood at 70% offline and 30% online, according to a Friday filing with the Shanghai bourse.The biopharmaceutical company is seeking to raise 1.80 billion yuan via the IPO of 65.3 million shares at 27.60 yuan apiece. Guotai Haitong Securities serves as lead underwriter, with China Galaxy Securities as joint lead underwriter.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}